| 1. |
劉慶榮, 陳陽, 許海燕, 等. 老年主動脈瓣狹窄患者經導管主動脈瓣置換術新進展[J]. 中國醫刊, 2022, 57(3): 233-236.Liu QR, Chen Y, Xu HY, et al. Advances in transcatheter aortic valve replacement for elderly patients with severe aortic stenosis[J]. Chin J Med, 2022, 57(3): 233-236.
|
| 2. |
中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 中國經導管主動脈瓣置換術臨床路徑專家共識(2021版)[J]. 中國介入心臟病學雜志, 2022, 30(1): 7-16.Structural Heart Disease Committee, Branch of Cardiovascular Physicians, Chinese Medical Doctor Association. Expert consensus on clinical pathway of transcatheter aortic valve replacement in China (2021 edition)[J]. Chin J Interv Cardiol, 2022, 30(1): 7-16.
|
| 3. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7): 561-632.
|
| 4. |
車波, 徐承義, 徐文杰, 等. 經股動脈經導管主動脈瓣置換術治療單純主動脈瓣反流的臨床可行性研究[J]. 中國胸心血管外科臨床雜志, 2024, 31(8): 1164-1173.Che B, Xu CY, Xu WJ, et al. Clinical feasibility of transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation[J]. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(8): 1164-1173.
|
| 5. |
封碩, 劉偉麗, 屈占軍, 等. 不同射血分數水平的重度主動脈瓣反流患者經導管主動脈瓣置換術后左心室逆重構的時間動力學分析[J]. 中國介入心臟病學雜志, 2026, 34(4): 181-188.Feng S, Liu WL, Qu ZJ, et al. Temporal kinetics of left ventricular reverse remodeling after transcatheter aortic valve replacement in patients with severe aortic regurgitation stratified by left ventricular ejection fraction[J]. Chin J Interv Cardiol, 2026, 34(4): 181-188.
|
| 6. |
國家心血管病專家委員會微創心血管外科專業委員會. 中國經導管主動脈瓣置入術(TAVI)多學科專家共識[J]. 中華胸心血管外科雜志, 2018, 34(12): 705-712.Minimally Invasive Cardiovascular Surgery Committee, National Expert Committee on Cardiovascular Diseases. Multidisciplinary expert consensus on transcatheter aortic valve implantation (TAVI) in China[J]. Chin J Thorac Cardiovasc Surg, 2018, 34(12): 705-712.
|
| 7. |
中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 經導管主動脈瓣置換術中國專家共識(2020更新版)[J]. 中國介入心臟病學雜志, 2020, 28(6): 301-309.Structural Heart Disease Committee, Branch of Cardiovascular Physicians, Chinese Medical Doctor Association. Chinese expert consensus on transcatheter aortic valve replacement (2020 updated version)[J]. Chin J Interv Cardiol, 2020, 28(6): 301-309.
|
| 8. |
Al-Attar N, Raffoul R, Himbert D, et al. False aneurysm after transapical aortic valve implantation[J/OL]. J Thorac Cardiovasc Surg, 2009, 137(1): e21-e22. DOI: 10.1016/j.jtcvs.2008.07.018.
|
| 9. |
申澤雪, 李樹仁, 李文靜, 等. 經導管主動脈瓣置換術的入徑選擇[J]. 中國介入心臟病學雜志, 2020, 28(8): 464-466.Shen ZX, Li SR, Li WJ, et al. Vascular access selection for transcatheter aortic valve replacement[J]. Chin J Interv Cardiol, 2020, 28(8): 464-466.
|
| 10. |
中華醫學會心血管病學分會結構性心臟病學組, 中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 中國經導管主動脈瓣置換術臨床路徑專家共識[J]. 中國介入心臟病學雜志, 2018, 26(12): 661-668.Structural Heart Disease Group, Cardiovascular Branch of Chinese Medical Association; Structural Heart Disease Committee, Branch of Cardiovascular Physicians, Chinese Medical Doctor Association. Expert consensus on clinical pathway of transcatheter aortic valve replacement in China[J]. Chin J Interv Cardiol, 2018, 26(12): 661-668.
|
| 11. |
Wernly B, Eder S, Navarese EP, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation: "on-label" versus "off-label" use of TAVR devices[J]. Clin Res Cardiol, 2019, 108(8): 921-930.
|
| 12. |
Huded CP, Allen KB, Chhatriwalla AK. Counterpoint: challenges and limitations of transcatheter aortic valve implantation for aortic regurgitation[J]. Heart, 2021, 107(24): 1942-1945.
|
| 13. |
張龍巖, 華正東, 宋丹, 等. 經導管主動脈瓣置換術治療單純主動脈瓣反流的臨床療效分析及經驗[J]. 中國介入心臟病學雜志, 2023, 31(11): 842-848.Zhang LY, Hua ZD, Song D, et al. Clinical efficacy and experience of transcatheter aortic valve replacement in patients with pure native aortic regurgitation[J]. Chin J Interv Cardiol, 2023, 31(11): 842-848.
|
| 14. |
Chen S, Zheng F, Li M, et al. A study on correlation between preprocedural CT indexes and procedural success rate of transfemoral transcatheter aortic valve replacement with different self-expanding valves (VitaFlow or VenusA-Valve) in patients with pure native aortic regurgitation[J/OL]. Ann Transl Med, 2022, 10(11): 643. DOI: 10.21037/atm-22-2588.
|
| 15. |
Zheng HJ, Cheng YB, Yan CJ, et al. Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation: one-year outcomes of a single-center study[J/OL]. BMC Cardiovasc Disord, 2023, 23(1): 330. DOI: 10.1186/s12872-023-03329-1.
|
| 16. |
Chen Y, Lu ZN, Yao J, et al. A novel anatomic classification to guide transcatheter aortic valve replacement for pure aortic regurgitation[J]. Echocardiography, 2022, 39(12): 1571-1580.
|
| 17. |
Dai H, Zhou D, Yidilisi A, et al. Self-expanding transcatheter aortic valve replacement for pure aortic regurgitation with extremely horizontal aorta: a case series[J/OL]. J Invasive Cardiol, 2022, 34(3): E257-E258. DOI: 10.25270/jic/21.00382.
|
| 18. |
金屏, 徐臣年, 翟蒙恩, 等. 股動脈經導管主動脈瓣置換治療單純主動脈瓣反流[J]. 中國體外循環雜志, 2022, 20(3): 160-164.Jin P, Xu CN, Zhai ME, et al. Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation[J]. Chin J Extracorporeal Circulation, 2022, 20(3): 160-164.
|
| 19. |
李捷, 孫英皓, 李光, 等. 經動脈入路經導管主動脈瓣置換術治療單純主動脈瓣反流的初步經驗[J]. 中國介入心臟病學雜志, 2021, 29(12): 678-683.Li J, Sun YH, Li G, et al. Preliminary experience of arterial access transcatheter aortic valve replacement for pure native aortic regurgitation[J]. Chin J Interv Cardiol, 2021, 29(12): 678-683.
|
| 20. |
程帥, 張錚, 曹豐, 等. 經股動脈途徑主動脈瓣置入術治療嚴重主動脈瓣反流效果觀察[J]. 臨床心血管病雜志, 2021, 37(11): 1051-1055.Cheng S, Zhang Z, Cao F, et al. Clinical observation of transfemoral transcatheter aortic valve implantation in patients with severe aortic regurgitation[J]. J Clin Cardiovasc Dis, 2021, 37(11): 1051-1055.
|
| 21. |
車波, 徐承義, 徐文杰, 等. 經股動脈經導管主動脈瓣置換術治療單純主動脈瓣反流的研究進展[J]. 中國介入心臟病學雜志, 2023, 31(3): 225-230.Che B, Xu CY, Xu WJ, et al. Research progress of transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation[J]. Chin J Interv Cardiol, 2023, 31(3): 225-230.
|
| 22. |
Wang H, Liu X, Yang Y, et al. TAVR for pure aortic regurgitation: a patient-specific simulation-based feasibility study[J]. JACC Asia, 2026, 6(3): 345-353.
|
| 23. |
Wang Z, Li T, Yang S, et al. Head-to-head comparison of transfemoral versus transapical TAVR for pure native aortic regurgitation: a multi-center retrospective cohort[J]. JACC Cardiovasc Interv, 2024, 17(22): 2611-2622.
|
| 24. |
Rudolph V, Kahlert P, Schaefer A, et al. Transcatheter heart valves devices for native aortic valve regurgitation: time for a change[J]? JACC Cardiovasc Interv, 2024, 17(21): 2412-2425.
|
| 25. |
Alkhawam H, Saba S, El-Sayed A, et al. Meta-analysis of dedicated vs. off-label transcatheter devices for native aortic regurgitation[J]. JACC Cardiovasc Interv, 2024, 17(20): 2301-2314.
|
| 26. |
De Luca L, Galli M, Ruggieri VG, et al. Redo transcatheter aortic valve replacement for migration of Myval transcatheter heart valve in pure aortic regurgitation[J/OL]. JACC Case Rep, 2025, 7(5): 104252. DOI: 10.1016/j.jaccas.2025.104252.
|
| 27. |
Stachon P, Kaier K, Heidt T, et al. Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015[J]. Catheter Cardiovasc Interv, 2020, 95(4): 810-816.
|
| 28. |
Tarantini G, Fabris T. Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun[J]. Catheter Cardiovasc Interv, 2020, 95(4): 817-818.
|
| 29. |
Takagi H, Hari Y, Kawai N, et al. Meta-analysis and metaregression of transcatheter aortic valve implantation for pure native aortic regurgitation[J]. Heart Lung Circ, 2020, 29(5): 729-741.
|
| 30. |
陳鑒濤, 張怡, 馮康倪, 等. 經導管主動脈瓣置換術治療重度單純自體主動脈瓣反流患者療效觀察[J]. 浙江大學學報(醫學版), 2025, 54(4): 529-540.Chen JT, Zhang Y, Feng KN, et al. Clinical efficacy of transcatheter aortic valve replacement in patients with severe pure native aortic regurgitation[J]. J Zhejiang Univ (Med Sci), 2025, 54(4): 529-540.
|
| 31. |
徐冰晨, 金健好, 陳莎莎, 等. 采用自膨脹瓣膜行經股動脈主動脈瓣置換術的全流程管理[J]. 介入放射學雜志, 2025, 34(3): 311-315.Xu BC, Jin JH, Chen SS, et al. Whole-process management of transfemoral transcatheter aortic valve replacement with self-expanding valves[J]. J Interv Radiol, 2025, 34(3): 311-315.
|
| 32. |
梁誠, 湯圣興, 張云龍, 等. 經導管主動脈瓣置換術治療單純自體主動脈瓣反流的進展[J]. 齊齊哈爾醫學院學報, 2025, 46(11): 1086-1090.Liang C, Tang SX, Zhang YL, et al. Research progress of transcatheter aortic valve replacement for pure native aortic regurgitation[J]. J Qiqihar Med Univ, 2025, 46(11): 1086-1090.
|
| 33. |
Feng X, Chen XJ, Weng ZL, et al. Noncoronary sinus pivot implantation (NCPI) strategy for transcatheter aortic valve replacement with self-expanding valve in pure native aortic regurgitation: a multicenter, registry study from the CCA database-NTCVR[J]. Cathet Cardiovasc Interv, 2025, 106(6): 3230-3238.
|
| 34. |
Huang L, Zhang H, Liu Y, et al. Three-dimensional anatomical predictors of valve migration and valve-in-valve after transfemoral TAVR in pure aortic regurgitation[J]. Catheter Cardiovasc Interv, 2026, 107(2): 412-421.
|
| 35. |
梁善福, 趙云飛, 張申偉, 等. TAVR和外科主動脈瓣置換術治療老年單純主動脈瓣反流的單中心經驗[J]. 中華心血管病雜志, 2026, 54(4): 435-441.Liang SF, Zhao YF, Zhang SW, et al. Single-center experience of TAVR versus surgical aortic valve replacement in elderly patients with pure native aortic regurgitation[J]. Chin J Cardiovasc Dis, 2026, 54(4): 435-441.
|